Virus Prevention Claims For RhinoSystems’ Naväge Flushed In Nasal Irrigation Advertising Review

During NAD review, RhinoSystems stated it previously pulled some COVID-19 prevention claims NeilMed challenged and pulled remaining ads after review began. Both RhinoSystems, which markets Naväge brand, and NeilMed, offering a namesake brand, were warned in 2021 by FTC about COVID-19 ad claims.

• Source: Shutterstock

An advertising dispute between two US nasal irrigation device firms was flushed out in a review by an industry self-regulation group, which found that one made unsupported virus prevention claims in TV and radio commercials.

BBB National Program Inc.’s National Advertising Division (NAD) reports that during its review, the firm, RhinoSystems Inc., stated that it...

More from Compliance

More from Policy & Regulation